Company intelligence / Profile preview

Shanxi Jinxin Shuanghe Pharmaceutical

Ownership: Private
Development stage: Other

Overview

The company is active in the commercial production and sale of pharmaceutical products such as ephedrine hydrochloride tablets and yuanhu painkiller tablets. No clinical trial data or development-stage pipeline was identified.

Therapeutic areas: PulmonologyNeurology
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Shanxi Jinxin Shuanghe Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanxi Jinxin Shuanghe Pharmaceutical.

Explore the full profile